According to the
GuruFocus All-in-One Screener
the following five companies reported the largest insider buys last
week. These are the largest insider buys in terms of transaction
amount, level of insider making buys and number of insiders buying.
Tessera Technologies (
Over the past week there have been three directors of Tessera
making notable buys back into the company. These three insiders
made five separate buys, adding 628,500 shares to their stake.
Director Peter Feld made the largest transaction by making three
buys and purchasing a total of 625,000. He purchased these shares
in the price range of $18.44 to $18.93 per share. The price per
share has dropped approximately -1.32%. Feld now owns 4.7 million
shares of Tessera stock.
Director George Riedel bought 1,500 shares at $18.82 per share.
This transaction cost the director a total of $28,230. Since his
buy, the price per share has dropped approximately -1.7%. Riedel
now owns at least 20,066 shares of company stock.
Director George Cwynar added 2,000 shares to his holdings at an
average price of $18.49 per share. The transaction cost the
director a total of $36,980. Since his buy, the price per share has
increased 0.05%. Cwynar now holds on to 20,226 shares of company
Tessera Technologies is a holding company with operating
subsidiaries in two segments: Intellectual Property and
Tessera Technologies' historical revenue and net income:
The analysis on Tessera Technologies reports that the company's P/E
ratio is at a 10-year high, its revenue has been in decline over
the past five years, its dividend yield is at a 2-year high and
that the company has no debt.
Tessera Technologies has a market cap of $996.9 million. Its shares
are currently trading at a P/E ratio of 166.00, a P/S ratio of 4.70
and a P/B ratio of 1.70. The company's dividend yield is currently
There are currently
that hold a position in TSRA.
Valeant Pharmaceuticals (
During the past week there have been two insiders that have made
notable buys into Valeant Pharmaceuticals.
Director Ronald Farmer bought 2,500 shares on Aug. 28. The director
bought these shares at an average price of $102.36 per share for a
total transaction amount of $255,900. Since this buy, the price per
share has dropped approximately -3.33%. Farmer now holds on to at
least 26,057 shares of company stock.
Executive VP, General Counsel and Corporate Secretary Robert
Chai-Onn purchased 5,032 shares on Aug. 23. The VP purchased these
shares at $99.30 per share for a total transaction amount of
$499,678. Since his buy the price per share has dropped
approximately -0.35%. Chai-Onn now holds on to a total of 188,277
shares of company stock.
These buys came as the price per share hit a 10-year high.
Valeant Pharmaceuticals is a multinational specialty pharmaceutical
company that develops, manufactures and markets a broad range of
pharmaceutical products primarily in the areas of neurology,
dermatology and branded generics.
Valeant Pharmaceuticals' historical revenue and net income:
The analysis on Valeant reports that the price is near a 10-year
high, the P/E ratio is at a 10-year high, the company has issued
$6.5 billion of debt over the past three years and that the
company's asset growth is faster than its revenue growth.
Valeant Pharmaceuticals has a market cap of $32.81 billion. Its
shares are currently trading at around $98.68 with a P/E ratio of
1041.60, a P/S ratio of 7.50 and a P/B ratio of 5.20. The company
had an annual average earnings growth of 4.2% over the past ten
There are currently 18 gurus that hold a position in Valeant
Multi-Color Corporation (
Over the past week two directors made buys into Multi-Color
Director Ari Benacerraf bought 12,000 shares on Aug. 23. The
director bought these shares at a price of $32.48 per share for a
total transaction amount of $389,760. Since his buy, the price per
share has dropped -3.33%.
Director Simon Roberts added a much smaller 2,400 shares to his
stake at an average cost of $32.42 per share. This cost him a total
of $77,808. Since his buy, the price per share has dropped -3.15%.
These insider buys were made as the company's price hit a 10-year
The Company provides a wide range of products for the packaging
needs of its customers and is a producer of high quality pressure
sensitive, in-mold and heat transfer labels, and a major
manufacturer of glue-applied and shrink sleeve labels.
Multi-Color's historical revenue and net income:
The analysis on Multi-Color reports that company has issued
$320.952 million of debt in the past three years, they have shown
predictable revenue and earnings growth, the operating margin is
expanding and their price is nearing a 10-year high.
The Peter Lynch Chart suggests that the company is currently
Multi-Color has a market cap of $514.4 million. Its shares are
currently trading at around $31.40 with a P/E ratio of 17.70, a P/S
ratio of 0.80 and a P/B ratio of 1.90. The company had an annual
average earnings growth of 14.3% over the past ten years.
GuruFocus rated Multi-Color the business predictability rank of
Joel Greenblatt and Jim Simons hold a position in Multi-Color
Independent Bank Group (
Over the past week Independent Bank Group reported eight insider
buys as coming from six different insiders. These buys come as the
share price has taken a slight drop.
The insiders making buys consisted of Director William Fair,
Director Stacy Smith, Executive VP and CFO Michelle Hickrox, Vice
Chairman and CLO Brian Hobart, Director Brian Aynesworth III and
President and COO Torry Berntsen.
These insiders bought a total of 28,718 shares of IBTX in the price
range of $34.02 to $35.07, with an estimated average price of
$34.49 per share. Since these buys the price per share has
increased approximately 2.1%.
Director William Fair bought a total of 14,192 shares at an average
price of $34.52 per share. These buys cost him a total of $491,960.
Since his buys, the share price has increased
Independent Bank Group is a holding company for Independent Bank
which provides a wide range of relationship-driven commercial
banking products and services tailored to meet the needs of
businesses, professionals and individuals. The company operates
offices in Dallas/Fort Worth and the greater Austin area.
Independent Bank's historical revenue and net income:
The company recently announced that they would be acquiring Live
Oak State Bank.
The analysis on Independent Bank Group reports that the price is
nearing a 52-week high and that the company has enough cash to
cover all of its debt.
Independent Bank Group has a market cap of $411.8 million. Its
shares are currently trading at around $34.12 with a P/E ratio of
13.90, a P/S ratio of 3.90 and a P/B ratio of 1.90.
Chuck Royce holds a stake in Independent Bank Group.
Check out a full list of the insider buys occurring this week
by looking at the GuruFocus Insider Trades Page.
Try a free 7-day premium membership here.
About GuruFocus: GuruFocus.com tracks the stocks picks and
portfolio holdings of the world's best investors. This value
investing site offers stock screeners and valuation tools. And
publishes daily articles tracking the latest moves of the world's
best investors. GuruFocus also provides promising stock ideas in 3
monthly newsletters sent to